MabCure, Inc. (MBCI)

Market Cap	390.54K -91.2%
Revenue (ttm)	500.00K
Net Income	-12.26M
EPS	-0.19
Shares Out	781.09M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,000
Average Volume	58,326
Open	0.0005
Previous Close	0.0002
Day's Range	0.0005 - 0.0005
52-Week Range	0.000001 - 0.0005
Beta	12.38
RSI	75.67
Earnings Date	n/a

About MabCure

MabCure Inc., a development stage company, engages in developing and commercializing its proprietary antibody technology for the early detection of cancer, and for the creation of specific therapeutics against cancer. It owns a proprietary technology for the generation of monoclonal antibodies against desired antigens, such as cancer markers. The company was formerly known as Smartec Holdings, Inc. and changed its name to MabCure Inc. in January 2008 to reflect its new business plan. MabCure Inc. was founded in 2006 and is based in White Plains...

• Industry: Solar
• Sector: Technology
• Founded: 2006
• Employees: 3
• Stock Exchange: OTCMKTS
• Ticker Symbol: MBCI